Could a popular Weight-Loss drug fix irregular periods in PCOS?
NCT ID NCT07326111
Summary
This study is testing if tirzepatide, a medication already approved for weight loss and diabetes, can improve ovarian function and regulate menstrual cycles in women with PCOS who are overweight or have obesity. About 200 premenopausal women in Germany will be randomly assigned to receive either tirzepatide or a placebo (dummy injection) for 72 weeks. The main goal is to see if the drug helps make periods more regular, which is a key sign of improved ovarian health in PCOS.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital BG Bergmannsheil Bochum General internal medicine, endocrinology and diabetology, gastroenterology and hepatology
ENROLLING_BY_INVITATIONBochum, 44789, Germany
-
University Hospital Bonn Division of Endocrinology, Diabetes and Metabolism
RECRUITINGBonn, 53127, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.